FOLH1 and metastatic neoplasm: While [<sup>68</sup>Ga]Ga-PSMA-11 PET-CT has demonstrated high diagnostic accuracy in detecting metastatic disease, the interpretation of indeterminate or potentially benign PSMA-avid bone lesions remains a clinical challenge in routine practice.<h4>Methods</h4>We conducted a retrospective single-centre study involving 214 patients who underwent [<sup>68</sup>Ga]Ga-PSMA-11 PET-CT between January 2021 and January 2024.